Traws Pharma, Inc. — Director's Dealing 2014

Dec 22, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2014-12-18

Reporting Person: Kumar Ramesh (Director, President and CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-12-18	Stock Option (right to purchase)	$3.98	A	175000	Acquired	2024-12-18	Common Stock (175000)	Direct

Footnotes

F1: These options vest over 4 years in 48 equal monthly installments.